The global diabetes care devices market is expected to grow from USD 1,987.65 million 2017 to USD 3,189.36 million by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 6.99%.

On the basis of product, the global diabetes care devices market is studied across Blood Glucose Monitoring Devices and Insulin Delivery Devices.

On the basis of geography, the global diabetes care devices market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).

"Abbott Laboratories: The potential growing player for the global diabetes care devices market"

The key players profiled in the global diabetes care devices market are Abbott Laboratories, Acon Laboratories, Inc., AgaMatrix, Inc., Arkray, Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Becton, Dickinson and Company, DexCom, Inc., Eli Lilly, F.Hoffmann-La Roche AG, Johnson & Johnson, LifeScan, Inc, Medtronic PLC, Novo Nordisk A/S, Roche Diagnostics Limited, Sanofi, Terumo Corporation, and Ypsomed Holding AG.


The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global diabetes care devices market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global diabetes care devices market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global diabetes care devices market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global diabetes care devices market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global diabetes care devices market.